×
戻る Agenda
LS11 Model-Informed Drug Development: Application of MIDD to the Development of Novel Drugs for Treatment of COVID-19 Has Changed the World
Session Chair(s)
So Miyoshi
Head of Clinical Pharmacology & Bioanalytics, Pfizer R&D Japan, Japan
Speaker(s)
Akiyuki Suzuki, MS
Senior Manager, Pharmacometrics Group, Clinical Pharmacology, Pfizer Japan Inc., Japan
Tsuyoshi Shiga
Associate Professor, Department of Cardiology, Tokyo Women's Medical University, Japan
Daisuke Iwata
Office of Asia Training Center and International cooperation, Pharmaceuticals and Medical Devices Agency, Japan